Q1 2026
Released May 14, 2026, after the close
10-Q filed May 14, 2026, 44 days after period end · 0001193125-26-224066
Q1 2026 · 10-Q
Revenue$186.98K$186.98K no prior Q1 2025 on fileno prior Q4 2025 on file
Net Income-$2.59M-$2.59M N/M vs Q1 2025N/M vs Q4 2025
EPS Diluted-$0.05-$0.05 N/M vs Q1 2025no prior Q4 2025 on file
Operating Income-$2,835,806N/M
Operating Cash Flow-$3,470,213N/M
Free Cash Flowderived-$3,481,038N/M
Margins · derived
Operating margin-1516.6%
Net margin-1383.1%
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q1 2026 | Q1 2025 | Q1 2024 | Q1 2022 |
|---|---|---|---|---|
| Revenue | $186.98K | — | — | — |
| Net Income | -$2.59M | -$2.86M | -$2.75M | -$4.03M |
| EPS Diluted | -$0.05 | -$0.06 | -$0.06 | -$0.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medicinova Inc · CIK 1226616 · Engraved from SEC EDGAR